JP2004528803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528803A5 JP2004528803A5 JP2001584514A JP2001584514A JP2004528803A5 JP 2004528803 A5 JP2004528803 A5 JP 2004528803A5 JP 2001584514 A JP2001584514 A JP 2001584514A JP 2001584514 A JP2001584514 A JP 2001584514A JP 2004528803 A5 JP2004528803 A5 JP 2004528803A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- nucleic acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20451800P | 2000-05-16 | 2000-05-16 | |
| US60/204,518 | 2000-05-16 | ||
| PCT/US2001/014468 WO2001088132A2 (en) | 2000-05-16 | 2001-05-04 | Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528803A JP2004528803A (ja) | 2004-09-24 |
| JP2004528803A5 true JP2004528803A5 (enExample) | 2008-06-19 |
| JP4819285B2 JP4819285B2 (ja) | 2011-11-24 |
Family
ID=22758233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001584514A Expired - Fee Related JP4819285B2 (ja) | 2000-05-16 | 2001-05-04 | 狂犬病ウイルス特異的ヒトモノクローナル中和抗体及び核酸及び関連する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6890532B2 (enExample) |
| EP (1) | EP1282703B1 (enExample) |
| JP (1) | JP4819285B2 (enExample) |
| AT (1) | ATE411387T1 (enExample) |
| CA (1) | CA2419148C (enExample) |
| DE (1) | DE60136174D1 (enExample) |
| IL (1) | IL152825A (enExample) |
| RU (1) | RU2272809C2 (enExample) |
| WO (1) | WO2001088132A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040013672A1 (en) * | 2000-05-16 | 2004-01-22 | Thomas Jefferson University | Recombinant antibodies, and compositions and methods for making and using the same |
| WO2002016437A2 (en) * | 2000-08-24 | 2002-02-28 | Thomas Jefferson University | Rhabdovirus-based vectors to express high levels of functional human antibodies |
| RU2292353C2 (ru) * | 2001-08-21 | 2007-01-27 | Томас Джефферсон Юниверсити | Рекомбинантные антитела и композиции, а также способы их создания и использования |
| US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| PT2314629E (pt) | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| EP2395016A3 (en) | 2003-05-30 | 2012-12-19 | Merus B.V. | Design and use of paired variable regions of specific binding molecules |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| JP5912211B2 (ja) | 2004-01-20 | 2016-04-27 | メルス ビー．ヴィー． | 結合タンパク質の混合物 |
| SI1851315T1 (sl) | 2005-02-02 | 2014-06-30 | University Of Massachusetts | Humana protitelesa proti steklini in njihova uporaba |
| JP2008263964A (ja) * | 2007-03-29 | 2008-11-06 | Yamaguchi Univ | コウモリ由来細胞株 |
| JP2010085126A (ja) * | 2008-09-29 | 2010-04-15 | Adtec Kk | 狂犬病ウイルス中和抗体価判定具および狂犬病ウイルス中和抗体価の測定方法 |
| KR101388680B1 (ko) * | 2011-03-18 | 2014-04-28 | (주)셀트리온 | 광견병 바이러스를 중화시킬 수 있는 결합 분자 |
| DK2838917T3 (da) | 2012-04-20 | 2019-08-26 | Merus Nv | Fremgangsmåder og midler til frembringelse af heterodimere ig-lignende molekyler |
| RU2533802C1 (ru) * | 2013-08-30 | 2014-11-20 | федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Тримеризованное однодоменное антитело, специфически связывающееся с гликопротеином g вируса бешенства, нейтрализующее вирус бешенства |
| WO2019227039A1 (en) * | 2018-05-24 | 2019-11-28 | Lankenau Institute For Medical Research | Compositions comprising antibodies to rabies virus and the uses thereof |
| CN111166877A (zh) * | 2019-12-30 | 2020-05-19 | 西安回天血液制品有限责任公司 | 一种狂犬病人免疫球蛋白的制备方法 |
| CN114958774B (zh) * | 2022-05-08 | 2023-10-27 | 中国医学科学院医学生物学研究所 | 抗狂犬病病毒单克隆抗体及分泌该抗体的杂交瘤细胞株与应用 |
| CN119431525B (zh) * | 2024-10-08 | 2025-04-11 | 北京溯本源和生物科技有限公司 | 狂犬病毒g蛋白重组抗原、单克隆抗体及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL89489A0 (en) | 1988-03-09 | 1989-09-10 | Hybritech Inc | Chimeric antibodies directed against human carcinoembryonic antigen |
| AU3432389A (en) * | 1988-04-07 | 1989-11-03 | Farmitalia Carlo Erba S.R.L. | Human monoclonal antibodies against rabies virus |
| JPH02503867A (ja) | 1988-04-15 | 1990-11-15 | プロテイン デザイン ラブズ インコーポレーテッド | Ｉｌ‐２レセプター特異的キメラ抗体 |
| ES2070172T3 (es) | 1988-04-16 | 1995-06-01 | Celltech Ltd | Procedimiento para producir proteinas mediante adn recombinante. |
| WO1993021319A1 (en) | 1992-04-08 | 1993-10-28 | Cetus Oncology Corporation | HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES |
-
2001
- 2001-05-04 IL IL152825A patent/IL152825A/en not_active IP Right Cessation
- 2001-05-04 DE DE60136174T patent/DE60136174D1/de not_active Expired - Lifetime
- 2001-05-04 JP JP2001584514A patent/JP4819285B2/ja not_active Expired - Fee Related
- 2001-05-04 AT AT01933020T patent/ATE411387T1/de not_active IP Right Cessation
- 2001-05-04 EP EP01933020A patent/EP1282703B1/en not_active Expired - Lifetime
- 2001-05-04 CA CA2419148A patent/CA2419148C/en not_active Expired - Fee Related
- 2001-05-04 WO PCT/US2001/014468 patent/WO2001088132A2/en not_active Ceased
- 2001-05-04 RU RU2002133470/13A patent/RU2272809C2/ru not_active IP Right Cessation
- 2001-05-04 US US09/848,832 patent/US6890532B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528803A5 (enExample) | ||
| JP2019195335A5 (enExample) | ||
| JP2002503495A5 (enExample) | ||
| CY1109715T1 (el) | IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ | |
| RU2007140978A (ru) | Пассивная иммунизационная терапия на основе пептидов для лечения атеросклероза | |
| CA2466629A1 (en) | Expression control using variable intergenic sequences | |
| RU2018119366A (ru) | Мыши с гуманизированной легкой цепью | |
| WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
| JP2007532098A5 (enExample) | ||
| FI3715372T3 (fi) | Suuren affiniteetin humaaneja vasta-aineita ihmisen IL-4-reseptorille | |
| JP2006516189A5 (enExample) | ||
| WO2001021810B1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DE60230918D1 (de) | Polycistronische expression von antikörpern in cho zellen | |
| CA2419148A1 (en) | Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods | |
| TR200401186T4 (tr) | Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları. | |
| CA2474801A1 (en) | Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity | |
| RU2002133470A (ru) | Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы | |
| CA2457362A1 (en) | Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same | |
| JP2025090679A5 (enExample) | ||
| JPWO2020233589A5 (enExample) | ||
| ATE417106T1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| WO1996021020A3 (en) | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | |
| CN112851771A (zh) | 连接核酸与蛋白或肽的方法 | |
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof |